24-26 March 2021 Rīga Stradiņš University (Virtual Great Hall)
- Insight into the plenary sessions
We face considerable challenges when it comes to ensuring that the most robust science is used to deliver justice, and that access to legal protections is made available to the greatest number of people. Technological innovation is enabling ever greater insights and capabilities, and is creating opportunities to obtain accurate intelligence and evidence more rapidly. However, the science applied within justice systems operates at a complex intersection of law, government, and community - creating a dynamic and interconnected environment with diverse and sometimes competing interests.
COVID-19 threatens to become one of the most difficult tests humanity has faced in modern history. As the pandemic has spread, it has taken lives, stirred anxiety and political drama, overwhelmed health systems, and triggered potentially lasting geopolitical change.
E-health involves a broad group of activities that use electronic means to deliver health-related information, resources and services: it is the use of information and communication technologies (ICT) for health. E-health encompasses a range of standards, tools and activities that use electronic means to deliver information, resources and services in relation to health and social care. At the heart of e-health is a vision of improving the quality of health information, strengthening national health systems and ensuring accessible, high-quality health care for all.
Why is e-health important? Member states in Europe are under increasing pressure to ensure that national health systems meet the demand for the delivery of high quality, readily available services in spite of zero-growth, or decreasing health budgets. Recent advances in mobile technologies, improvements in broadband coverage and the growing acceptance of tele-health and mobile health (m-health) solutions are providing new and attractive options for delivering health care. As a result, many governments are investing in e-health as a means of reforming health systems and for ensuring equitable and affordable access to health care.
The ultimate goal of Precision Medicine, also referred to as Personalised Medicine, is to enable the use of information about a patient’s genes and environment. Physicians and scientists can utilise this data in order to identify or predict diseases, delay or prevent the onset of disease, and develop effective treatment more accurately. This could be aided by sciences like genomics, developing technology to better parse massive data sets, and by improving our understanding of the relationship between differences in DNA and basic biological mechanisms. However, Precision Medicine faces challenges related to the healthcare workforce, costs, equal access to care, and data privacy.
Everyone must be empowered to master artificial intelligence.
Technology innovation in the realm of robotics and artificial intelligence is fundamentally transforming education, and updating the skills required to succeed in workplaces and classrooms. Building future-ready education systems requires curricula fit for the 21st century, and the consistent delivery of freely-available education for everyone.
24 March Virtual
10:00–10:30 'The state’s legitimate influence on individuals' personal freedom'
(Egils Levits, President of Latvia)
10:30 - 10:45 LMT, TBC 10:45–11:15 'The Politics of Emptiness in the Time of the Pandemic'
(Dace Dzenovska, University of Oxford, United Kingdom)
11:15–11:30 'Covid-19: science for everyday practice'
(Ludmila Vīksna, RSU)
25 March Virtual
(Janek Metsallik, Tallinn University of Technology, Estonia)
9:00–9:30 'Biomaterials/Predictive Medicine'
(Mauro Alini, AO Foundation, Davos, Switzerland)
26 March Virtual
8:30–9:00 'Technology- and data-driven molecular precision medicine'
(Olli Kallioniemi, SciLifeLab, Stockholm, Sweden)
9:00–9:30 'Genotypes of complex diseases and its application in precision medicine'
(Andreas Metspalu, Head of the Estonian Biobank, Tartu, Estonia)
9:30–10:00 'Modern regenerative medicine – hematopoietic stem cell niche'
(Robert Oostendorp, Technical University of Munich, Munich, Germany)
- Plenary Speakers